Elevance Health stock rises but underperforms rivals

13 articles · Updated · MarketWatch · May 8

The shares gained 1.38% to $378.07 on Friday as the S&P 500 rose 0.84% and the Dow Jones Industrial Average added 0.02%.
UnitedHealth climbed 2.77%, Cigna rose 1.42% and Humana jumped 11.27%, leaving Elevance behind peers despite the broader market's positive session.
Elevance closed 10.88% below its 52-week high of $424.24 reached on May 12, while trading volume of 1.3 million stayed well below its 50-day average.

With insiders buying and a massive valuation gap, is Elevance Health a bargain or a value trap?

Can agentic AI fix the deep compliance failures that are plaguing Elevance Health and unlock its value?

Why did a health giant risk sanctions using USB drives while rivals soared on favorable new government rules?